Sandy Hmadeh

Strasbourg, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Rheumatic Heart Disease: Inflammation, Immune Pathways, Valve Remodeling, and the Promise of SGLT2 Inhibitors.

Rheumatic Heart Disease: Inflammation, Immune Pathways, Valve Remodeling, and the Promise of SGLT2 Inhibitors.

Journal: JACC. Basic to translational science
Published: February 05, 2026

Detrimental Effect of Plasma From Patients With Severe Aortic Stenosis on Valvular Endothelial Cells: Role of Proinflammatory Cytokines and Factor Xa.

Detrimental Effect of Plasma From Patients With Severe Aortic Stenosis on Valvular Endothelial Cells: Role of Proinflammatory Cytokines and Factor Xa.

Journal: Journal of the American Heart Association
Published: November 26, 2025

Transcatheter Aortic Valve Durability: Focus on Structural Valve Deterioration.

Transcatheter Aortic Valve Durability: Focus on Structural Valve Deterioration.

Journal: Journal of the American Heart Association
Published: June 18, 2025

SGLT2 Inhibition Mechanisms in Aortic Stenosis and Following Transcatheter Aortic Valve Replacement.

SGLT2 Inhibition Mechanisms in Aortic Stenosis and Following Transcatheter Aortic Valve Replacement.

Journal: JACC. Cardiovascular interventions
Published: March 19, 2025

Potential of dapagliflozin to prevent vascular remodeling in the rat carotid artery following balloon injury.

Potential of dapagliflozin to prevent vascular remodeling in the rat carotid artery following balloon injury.

Journal: Atherosclerosis
Published: August 26, 2023

Human Aortic Stenotic Valve-Derived Extracellular Vesicles Induce Endothelial Dysfunction and Thrombogenicity Through AT1R/NADPH Oxidases/SGLT2 Pro-Oxidant Pathway.

Human Aortic Stenotic Valve-Derived Extracellular Vesicles Induce Endothelial Dysfunction and Thrombogenicity Through AT1R/NADPH Oxidases/SGLT2 Pro-Oxidant Pathway.

Journal: JACC. Basic to translational science
Published: May 10, 2023

Determinants and treatments of heart failure after transcatheter aortic valve implantation: moving up a notch.

Determinants and treatments of heart failure after transcatheter aortic valve implantation: moving up a notch.

Journal: ESC heart failure
Published: October 26, 2022

Aortic stenosis and the haemostatic system.

Aortic stenosis and the haemostatic system.

Journal: Cardiovascular research
Published: July 19, 2022

Letter by Trimaille et al Regarding Article, "Native Aortic Valve Disease Progression and Bioprosthetic Valve Degeneration in Patients With Transcatheter Aortic Valve Implantation".

Letter by Trimaille et al Regarding Article, "Native Aortic Valve Disease Progression and Bioprosthetic Valve Degeneration in Patients With Transcatheter Aortic Valve Implantation".

Journal: Circulation
Published: April 11, 2022

Reply to "Patients with aortic stenosis exhibit early improved endothelial function following transcatheter aortic valve replacement: The eFAST study" by Comella et al.

Reply to "Patients with aortic stenosis exhibit early improved endothelial function following transcatheter aortic valve replacement: The eFAST study" by Comella et al.

Journal: International journal of cardiology
Published: April 17, 2021

The adiponectin agonist, AdipoRon, inhibits steroidogenesis and cell proliferation in human luteinized granulosa cells.

The adiponectin agonist, AdipoRon, inhibits steroidogenesis and cell proliferation in human luteinized granulosa cells.

Journal: Molecular and cellular endocrinology
Published: August 09, 2020
Showing 1-11 of 11

Last Updated: 09/26/2026